XML 66 R52.htm IDEA: XBRL DOCUMENT v3.25.3
Organization and Business Description - Schedule of Subsidiaries (Details)
 12 Months Ended
Jun. 30, 2025
Lakeside Holding Limited [Member]  
Parent Company  
Date of Incorporation/ Acquisition Aug. 28, 2023
Jurisdiction of Formation Nevada
Principal Activities Holding company
American Bear Logistics Corp. (“ABL Chicago”) [Member]  
Parent Company  
Date of Incorporation/ Acquisition Feb. 05, 2018
Jurisdiction of Formation Illinois
Percentage of direct/indirect Economic Ownership 100.00%
Principal Activities Logistics services
Sichuan Hupan Jincheng Enterprise Management Co., Ltd (“Sichuan Hupan”) [Member]  
Parent Company  
Date of Incorporation/ Acquisition Jul. 10, 2024 [1]
Jurisdiction of Formation Sichuan, China [1]
Percentage of direct/indirect Economic Ownership 100.00% [1]
Principal Activities Exploring business opportunities in China [1]
Hupan Pharmaceutical (Hubei) Co., Ltd (“Hupan Pharmaceutical”) [Member]  
Parent Company  
Date of Incorporation/ Acquisition Nov. 21, 2024 [2]
Jurisdiction of Formation Hubei, China [2]
Percentage of direct/indirect Economic Ownership 100.00% [2]
Principal Activities Medical injection and pharmaceutical distributor [2]
Wuhan Hupan New Energy Technology limited Co., Ltd (“Hupan New Energy”) [Member]  
Parent Company  
Date of Incorporation/ Acquisition Dec. 12, 2024 [3]
Jurisdiction of Formation Wuhan, China [3]
Percentage of direct/indirect Economic Ownership [3]
Principal Activities Dormant [3]
Wuhan Ruixinda Technology Limited Co., Ltd (“Wuhan Ruixinda”) [Member]  
Parent Company  
Date of Incorporation/ Acquisition Dec. 20, 2024 [3]
Jurisdiction of Formation Wuhan, China [3]
Percentage of direct/indirect Economic Ownership [3]
Principal Activities Dormant [3]
[1] On July 10, 2024, the Company incorporated a wholly-owned subsidiary, Sichuan Hupan Jincheng Enterprise Management Co., Ltd, in China. The Company is actively exploring the potential business opportunities in mainland China.
[2] On November 5, 2024, Sichuan Hupan entered into an equity transfer agreement (the “Equity Transfer Agreement”), through which the Company acquired 100% of the equity interests in Hupan Pharmaceutical, a comprehensive pharmaceutical distribution and supply chain service provider, for a total net consideration of $0.3 million (see Note 20). The transaction was completed on November 21, 2024.
[3] On April 8, 2025 and May 12, 2025, Hupan New Energy and Wuhan Ruixinda were deregistered, respectively.